260 results on '"Schillberg S"'
Search Results
2. The Production of Recombinant Antibodies in Plants and Plant Cells
- Author
-
Fischer, R., Emans, N., Schillberg, S., Erickson, L., editor, Yu, W.-J., editor, Brandle, J., editor, and Rymerson, R., editor
- Published
- 2002
- Full Text
- View/download PDF
3. Modulation of Plant Function and Plant Pathogens by Antibody Expression
- Author
-
Fischer, R., Drossard, J., Schillberg, S., Artsaenko, O., Emans, N., Naehring, J. M., Verpoorte, Robert, editor, and Alfermann, A. W., editor
- Published
- 2000
- Full Text
- View/download PDF
4. ANTIBODY-BASED PATHOGEN RESISTANCE IN PLANTS
- Author
-
Nölke, G., Fischer, R., and Schillberg, S.
- Published
- 2004
5. Targeted mutagenesis in Nicotiana tabacum ADF gene using shockwave-mediated ribonucleoprotein delivery increases osmotic stress tolerance
- Author
-
Augustine, S.M., Cherian, A.V., Seiling, K., Fiore, S. Di, Raven, N., Commandeur, U., Schillberg, S., and Publica
- Abstract
DNA-free genome editing involves the direct introduction of ribonucleoprotein (RNP) complexes into cells, but this strategy has rarely been successful in plants. In the present study, we describe a new technique for the introduction of RNPs into plant cells involving the generation of cavitation bubbles using a pulsed laser. The resulting shockwave achieves the efficient transfection of walled cells in tissue explants by creating transient membrane pores. RNP-containing cells were rapidly identified by fluorescence microscopy, followed by regeneration and the screening of mutant plants by high-resolution melt analysis. We used this technique in Nicotiana tabacum to target the endogenous phytoene desaturase (PDS) and actin depolymerizing factor (ADF) genes. Genome-edited plants were produced with an efficiency of 35.2% for PDS and 16.5% for ADF. Further we evaluated the physiological, cellular and molecular effects of ADF mutations in T2 mutant plants under drought and salinity stress. The results suggest that ADF acts as a key regulator of osmotic stress tolerance in plants.
- Published
- 2021
6. Molecular farming of recombinant antibodies in plants
- Author
-
Schillberg, S., Fischer, R., and Emans, N.
- Published
- 2003
- Full Text
- View/download PDF
7. Transient transformation of the rust fungus Puccinia graminis f. sp. tritici
- Author
-
Schillberg, S., Tiburzy, R., and Fischer, R.
- Published
- 2000
- Full Text
- View/download PDF
8. Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11–16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures
- Author
-
Ramirez, E., Hernádez, A., Ham, E., Barrón, B. L., Ding, S. W., Li, W. X., Shi, B. J., Symons, R. H., Li, Q., Ryu, K. H., Palukaitis, P., Kaplan, I. B., Palukaitis, P., Kaplan, I. B., Palukaitis, P., Gal-On, A., Kunhara, J., Otsubo, T., Tomaru, K., Tsuda, S., Kinta, M., Lin, T., Johnson, J. E., Porta, C., Taylor, K. M., Spall, V. E., Lomonossoff, G. P., Spall, V. E., Porta, C., Lomonossoff, G. P., Gal-On, A., Meiri, E., Raccah, B., Gaba, V., Ikegami, M., Kawashima, H., Murayama, A., Natsuaki, T., Kageyama, Y., Sugimura, N., Thole, V., Bol, J. F., Deiman, B. A. L. M., Koenen, A. K., Pleij, C. W. A., Chaleeprom, W., Bateson, M. F., Dale, J. L., Badge, J. L., Foster, G. D., Brunt, A. A., Robinson, D., Schubert, J., Rabenstein, F., Merits, A., Yeh, Shyi-Dong, Chiang, Chu-Hui, Wang, Ching-Hsien, Chiang, Chu-Hui, Yeh, Shyi-Dong, Golshani, A., Ivanov, I. G., AbouHaidar, M. G., Rodoni, B. C., Harding, R. M., Bateson, M. F., Dale, J. L., Oertel, U., Fuchs, E., Schubert, J., Yang, S. J., Revere, F., Walter, J., Le Gall, O., Dunez, J., Candresse, T., Lot, H., Souche, S., Kasschau, Kristin D., Carrington, James C., Chiang, A. N., Turner, N. E., Hwang, D. J., Chachulska, A. M., Zagórski, W., Robaglia, C., Chrzanowska, M., Truve, E., Tamm, T., Saarma, M., Makinen, K., Wang, Aiming, Carrier, Karma, Wieczorek, Andrew, Huguenot, Claire, Sanfacon, Helene, Wurscher, M. A., Christensen, F. E., Prody, G. A., Sanchez-Navarro, J. A., Pallas, V., Carson, R., Dagless, E., Lock, S., Turner, R., Foster, G. D., Badge, J. L., Adams, M., Antoniw, J., Brunt, A. A., Phillips, S., Kashiwazaki, S., Seal, S., Karamagioli, M., Druka, Amis, Makhdoom, Rahat, Yitang, Yan, Hull, Roger, Kikkert, M., Bodegom, P., Storms, M., van Lent, J., Kormelink, R., Goldbach, R., De Haan, P., De Rover, A. R., Van Schepen, A., Gielen, J. J. L., Van Grinsven, M. Q. J. M., Livneh, O., Vardi, E., Kuznetsova, L., Aliskevicius, E., Stram, Y., Sela, I., Dinant, S., Kusiak, C., Blaise, F., Chupeau, Y., Astier, S., Albouy, J., Clifford, T. B., Taylor, S. C., Stratford, R., Foster, G. D., Xiao, X. W., Frenkel, M. J., Chu, P., Tabe, L., Shukla, D. D., Ward, C. W., Hwang, Duk-Ju, Turner, Nilgun, Taylor, S. C., Mooney, A., MacFarlane, S. A., Twell, D., Foster, G. D., Jacquet, C., Ravelonandro, M., Bachelier, J. C., Dunez, J., Almási, A., Böddi, B., Szigeti, Z., Ekes, M., Gaborianvi, R., Yankulova, Margarita, Ivanova, Lidia, Adam, G., Guelemerov, S., Nikolaeva, Velitchka, Atanassov, A., Prins, Marcel, de Haan, Peter, Goldbach, Rob, Duan, Y. P., Powell, C. A., Purcifull, D. E., Hiebert, E., Levine, B., Faktor, O., Zeituny, Silvy, Edelbaum, Orit, Sela, L., Marano, Maria-Rosa, Ratcliff, Frank, Baulcombe, David C., van Oers, Monique M., Linthorst, Huub J. M., Bol, John F., Schillberg, S., Zimmermann, S., Drossard, J., Schumann, D., Nahring, J., Fischer, R., Lapidot, Moshe, Arce-Johnson, Patricio, Rivera-Bustamante, Rafael, Beachy, Roger N., Cassidy, Brandt G., Flasinski, Stanislaw, Hajimorad, M. R., Wesley, Varsha, Angel-Diaz, J., Mayo, M. A., Hafner, G. J., May, G. D., Becker, D. K., Harding, R. M., Arntzen, C. J., Dale, J. L., Taylor, S. C., Porter, J., Foster, G. D., Palukaitis, P., Hellwald, K. H., Banerjee, N., Zaitlin, M., Gal-On, A., Wolf, D., Faure, J. E., Pilowsky, M., Cohen, S., Zelcer, A., Hardi, V., Tomassoli, L., Kaniewski, W. K., Mitsky, T., Barba, M., Hou, Y. -M., Ursin, V. M., Sanders, R., Gilbertson, R. L., Gruden, Kristina, Štrukelj, Borut, Brzin, Joze, Ravnikar, Maja, Maganja, Darja Barlič, Kregar, Igor, Maki-Valkama, T., Pehu, T., Valkonen, J., Lento, K., Pehu, E., Zaitlin, M., Kaniewski, W. K., Lawson, E. C., Feldman, J., Zalewski, J., Saarma, M., Kuittinen, T., Valkonen, J., Atiri, G. I., Romero, A., Arroyo, R., Soto, M. J., Martínez-Zapater, J. M., Ponz, F., Gilardi, P., López, L., García-Luque, I., Serra, M. T., Pang, Sheng-Zhi, Jan, Fuh-Jyh, Carney, Kim, Tricoli, David M., Quemada, Hector D., Gonsalves, Dennis, Aboul-Ata, A. E., Thouvenel, J. -C., Marshall, D., Abo-El-Saad, Sh., Satour, M., Mazithulela, G., Mehlo, L., Gahakwa, D., Leech, M., Boulton, M. I., Davies, J. W., Christou, P., Huet, H., Sivamani, E., Ong, C. A., Chen, L., de Kochko, A., Beachy, R. N., Fauquet, C. M., Sithisarn-Burns, P., Maugeri, M. M., Dale, J. L., Smith, G. R., Harding, R. M., Handley, J. A., Harding, R. M., Smith, G. R., Dale, J. L., Graichen, K., Peterka, J., Chu, Paul, Larkin, Phil, Higgins, T. J., Wylie, S., Jones, M. G. K., Somsap, V., Loo, H. P., Li, D., Mathews, A., Jones, M. G. K., Dwyer, G. I., Jones, M. G. K., McCarthy, P. L., Hansen, J., Shiel, P. J., Zemetra, R. S., Wyatt, S. D., Berger, P. H., Ford, C., Collins, N., Rathjen, J., Shams-Bakhsh, M., Paltridge, N., Symons, R. H., Aboul-Ata, A. E., Makkouk, K. M., El-Saied, M. A., El-Hariry, M., Salem, G., Soliman, N. H., Rishi, Narayan, Lodhi, G. P., Bishnoi, S. S., Sangwan, R. B., Sijen, Titia, Wellink, Joan, van Kammen, Ab, Ravelonandro, M., Scorza, R., Bachelier, J., Callahan, A., Levy, L., Dunez, J., Polák, J., Oukropec, I., Kominek, P., Bitoova, M., Cardol, Erwin, Prins, Marcel, Kormelink, Richard, Goldbach, Rob, Baulcombe, D. C., English, J. J., Davenport, G., Ruiz-Perez, T., Mueller, E., Truve, E., Nigul, L., Saarma, M., Kelve, M., Fedorkin, O. N., Denisenko, O. N., Zelenina, D. A., Morozov, S. Yu., Atabekov, J. G., Laliberté, J. -F., Wittmann, S., Plante, Daniel, Fortin, Marc G., Chatel, H., Rodriguez-Alvarado, G., Garcia-Arenal, F., Roossinck, M. J., Palukaitis, P., Roossinck, M. J., Palukaitis, P., Gellatly, D. L., AbouHaidar, M. G., Rasochova, L., Aulik, M., Passmore, B., Falk, B., Miller, W. A., Lin, Na-Sheng, Lin, Biing-Yuan, Hsu, Yau-Heiu, Tamada, T., Kiguchi, T., Saito, M., Kusume, T., Uchino, H., Taliansky, M., Robinson, D., DiSerio, F., Daròs, J. A., Ragozzino, A., Floras, R., Hohn, Thomas, Chen, Gang, Rothnie, Helen, Corsten, Sandra, Fütterer, Johannes, Mikhailov, M. V., Bishop, D. H. L., and Roy, P.
- Published
- 1997
- Full Text
- View/download PDF
9. Generation and evaluation of movement protein-specific single-chain antibodies for delaying symptoms of Tomato spotted wilt virus infection in tobacco
- Author
-
Zhang, M.-Y., Zimmermann, S., Fischer, R., and Schillberg, S.
- Published
- 2008
10. Monoclonal Antibody AP3 Binds Galactomannan Antigens Displayed by the Pathogens Aspergillus flavus, A. fumigatus, and A. parasiticus
- Author
-
Schubert, M., Xue, S., Ebel, F., Vaggelas, A., Krylov, V.B., Nifantiev, N.E., Chudobova, I., Schillberg, S., Nölke, G., and Publica
- Subjects
Antigens, Fungal ,Cross Reactions ,Immunologic Tests ,Mannans ,Epitopes ,Mice ,Cellular and Infection Microbiology ,glycobiology ,Cell Wall ,galactofuranose ,Animals ,Aspergillosis ,Antibodies, Fungal ,Original Research ,Mice, Inbred BALB C ,Aspergillus fumigatus ,Polysaccharides, Bacterial ,detection assay ,Antibodies, Monoclonal ,Galactose ,epitope identification ,Aspergillus antigen ,Recombinant Proteins ,Disease Models, Animal ,Aspergillus ,Female ,Aspergillus flavus - Abstract
Aspergillus fumigatus and A. flavus are the fungal pathogens responsible for most cases of invasive aspergillosis (IA). Early detection of the circulating antigen galactomannan (GM) in serum allows the prompt application of effective antifungal therapy, thus improving the survival rate of IA patients. However, the use of monoclonal antibodies (mAbs) for the diagnosis of IA is often associated with false positives due to cross-reaction with bacterial polysaccharides. More specific antibodies are therefore needed. Here we describe the characterization of the Aspergillus-specific mAb AP3 (IgG1k), including the precise identification of its corresponding antigen. The antibody was generated using A. parasiticus cell wall fragments and was shown to bind several Aspergillus species. Immunofluorescence microscopy revealed that AP3 binds a cell wall antigen, but immunoprecipitation and enzyme-linked immunosorbent assays showed that the antigen is also secreted into the culture medium. The inability of AP3 to bind the A. fumigatus galactofuranose (Galf )-deficient mutant DglfA confirmed that Galf residues are part of the epitope. Several lines of evidence strongly indicated that AP3 recognizes the Galf residues of O-linked glycans on Aspergillus proteins. Glycoarray analysis revealed that AP3 recognizes oligo-[v-D-Galf-1,5] sequences containing four or more residues with longer chains more efficiently. We also showed that AP3 captures GM in serum, suggesting it may be useful as a diagnostic tool for patients with IA.
- Published
- 2019
11. The Integration of Algal Carbon Concentration Mechanism Components into Tobacco Chloroplasts Increases Photosynthetic Efficiency and Biomass
- Author
-
Nölke, G., Barsoum, M., Houdelet, M., Arcalis, E., Kreuzaler, F., Fischer, R., Schillberg, S., and Publica
- Abstract
Increasing the productivity of crops is a major challenge in agricultural research. Given that photosynthetic carbon assimilation is necessary for plant growth, enhancing the efficiency of photosynthesis is one strategy to boost agricultural productivity. The authors attempted to increase the photosynthetic efficiency and biomass of tobacco plants by expressing individual components of the Chlamydomonas reinhardtii carbon concentration mechanism (CCM) and integrating them into the chloroplast. Independent transgenic varieties are generated accumulating the carbonic anhydrase CAH3 in the thylakoid lumen or the bicarbonate transporter LCIA in the inner chloroplast membrane. Independent homozygous transgenic lines showed enhanced CO2 uptake rates (up to 15%), increased photosystem II efficiency (by up to 18%), and chlorophyll content (up to 19%). Transgenic lines produced more shoot biomass than wild‐type and azygous controls, and accumulated more carbohydrate and amino acids, reflecting the higher rate of photosynthetic CO2 fixation. These data demonstrate that individual algal CCM components can be integrated into C3 plants to increase biomass, suggesting that transgenic lines combining multiple CCM components could further increase the productivity and yield of C3 crops.
- Published
- 2019
12. Toward Molecular Farming of Therapeutics in Plants
- Author
-
Fischer, R., primary, Schillberg, S., additional, and Emans, N., additional
- Published
- 2000
- Full Text
- View/download PDF
13. Polyamines delay leaf maturation in low‐alkaloid tobacco varieties
- Author
-
Nölke, G., Volke, D., Chudobová, I., Houdelet, M., Lusso, M., Frederick, J., Adams, A., Kudithipudi, C., Warek, U., Strickland, J.A., Xu, D., Schinkel, H., Schillberg, S., and Publica
- Abstract
The development of low‐alkaloid (LA) tobacco varieties is an important target in the tobacco breeding industry. However, LA Burley 21 plants, in which the Nic1 and Nic2 loci controlling nicotine biosynthesis are deleted, are characterized by impaired leaf maturation that leads to poor leaf quality before and after curing. Polyamines are involved in key developmental, physiological, and metabolic processes in plants, and act as anti‐senescence and anti‐ripening regulators. We investigated the role of polyamines in tobacco leaf maturation by analyzing the free and conjugated polyamine fractions in the leaves and roots of four Burley 21 varieties: NA (normal alkaloid levels, wild‐type control), HI (high intermediates, nic2−), LI (low intermediates, nic1−), and LA (nic1−nic2−). The pool of conjugated polyamines increased with plant age in the roots and leaves of all four varieties, but the levels of free and conjugated putrescine and spermidine were higher in the LI and LA plants than NA controls. The increase in the polyamine content correlated with delayed maturation and senescence, i.e., LA plants with the highest polyamine levels showed the most severe impaired leaf maturation phenotype, characterized by higher chlorophyll content and more mesophyll cells per unit leaf area. Treatment of LA plants with inhibitors of polyamine biosynthesis and/or the growth regulator Ethephon® reduced accumulation of polyamines, achieving a partial amelioration of the LA phenotype. Our data show that the regulation of polyamine homeostasis is strongly disrupted in LA plants, and that free and conjugated polyamines contribute to the observed impairment of leaf maturation.
- Published
- 2018
14. Plant-derived chimeric antibodies inhibit the invasion of human fibroblasts by Toxoplasma gondii
- Author
-
Lim, S.S.Y., Chua, K.H., Nölke, G., Spiegel, H., Goh, W.L., Chow, S.C., Kee, B.P., Fischer, R., Schillberg, S., Othman, R.Y., and Publica
- Abstract
The parasite Toxoplasma gondii causes an opportunistic infection, that is, particularly severe in immunocompromised patients, infants, and neonates. Current antiparasitic drugs are teratogenic and cause hypersensitivity-based toxic side effects especially during prolonged treatment. Furthermore, the recent emergence of drug-resistant toxoplasmosis has reduced the therapeutic impact of such drugs. In an effort to develop recombinant antibodies as a therapeutic alternative, a panel of affinity-matured, T. gondii tachyzoite-specific single-chain variable fragment (scFv) antibodies was selected by phage display and bioinformatic analysis. Further affinity optimization was attempted by introducing point mutations at hotspots within light chain complementarity-determining region 2. This strategy yielded four mutated scFv sequences and a parental scFv that were used to produce five mouse-human chimeric IgGs in Nicotiana benthamiana plants, with yields of 33-72 mg/kg of plant tissue. Immunological analysis confirmed the specific binding of these plant-derived antibodies to T. gondii tachyzoites, and in vitro efficacy was demonstrated by their ability to inhibit the invasion of human fibroblasts and impair parasite infectivity. These novel recombinant antibodies could therefore be suitable for the development of plant-derived immunotherapeutic interventions against toxoplasmosis.
- Published
- 2018
15. Aspergillus-specific antibodies: Targets and applications
- Author
-
Schubert, M., Spiegel, H., Schillberg, S., Nölke, G., and Publica
- Abstract
Aspergillus is a fungal genus comprising several hundred species, many of which can damage the health of plants, animals and humans by direct infection and/or due to the production of toxic secondary metabolites known as mycotoxins. Aspergillus-specific antibodies have been generated against polypeptides, polysaccharides and secondary metabolites found in the cell wall or secretions, and these can be used to detect and monitor infections or to quantify mycotoxin contamination in food and feed. However, most Aspergillus-specific antibodies are generated against heterogeneous antigen preparations and the specific target remains unknown. Target identification is important because this can help to characterize fungal morphology, confirm host penetration by opportunistic pathogens, detect specific disease-related biomarkers, identify new candidate targets for antifungal drug design, and qualify antibodies for diagnostic and therapeutic applications. In this review, we discuss how antibodies are raised against heterogeneous Aspergillus antigen preparations and how they can be characterized, focusing on strategies to identify their specific antigens and epitopes. We also discuss the therapeutic, diagnostic and biotechnological applications of Aspergillus-specific antibodies.
- Published
- 2018
16. Abstracts of presentations on plant protection issues at the xth international congress of virology: August 11-16,1996 Binyanei haOoma, Jerusalem, Israel Part 2 Plenary Lectures
- Author
-
Ramirez, E., Hernádez, A., Ham, E., Barrón, B., Ding, S., Li, W., Shi, B., Symons, R., Li, Q., Ryu, K., Palukaitis, P., Kaplan, I., Gal-On, A., Kunhara, J., Otsubo, T., Tomaru, K., Tsuda, S., Kinta, M., Lin, T., Johnson, J., Porta, C., Taylor, K., Spall, V., Lomonossoff, G., Meiri, E., Raccah, B., Gaba, V., Ikegami, M., Kawashima, H., Murayama, A., Natsuaki, T., Kageyama, Y., Sugimura, N., Thole, V., Bol, J., Deiman, B., Koenen, A., Pleij, C., Chaleeprom, W., Bateson, M., Dale, J., Badge, J., Foster, G., Brunt, A., Robinson, D., Schubert, J., Rabenstein, F., Merits, A., Yeh, Shyi-Dong, Chiang, Chu-Hui, Wang, Ching-Hsien, Golshani, A., Ivanov, I., AbouHaidar, M., Rodoni, B., Harding, R., Oertel, U., Fuchs, E., Yang, S., Revere, F., Walter, J., Le Gall, O., Dunez, J., Candresse, T., Lot, H., Souche, S., Kasschau, Kristin, Carrington, James, Chiang, A., Turner, N., Hwang, D., Chachulska, A., Zagórski, W., Robaglia, C., Chrzanowska, M., Truve, E., Tamm, T., Saarma, M., Makinen, K., Wang, Aiming, Carrier, Karma, Wieczorek, Andrew, Huguenot, Claire, Sanfacon, Helene, Wurscher, M., Christensen, F., Prody, G., Sanchez-Navarro, J., Pallas, V., Carson, R., Dagless, E., Lock, S., Turner, R., Adams, M., Antoniw, J., Phillips, S., Kashiwazaki, S., Seal, S., Karamagioli, M., Druka, Amis, Makhdoom, Rahat, Yitang, Yan, Hull, Roger, Kikkert, M., Bodegom, P., Storms, M., van Lent, J., Kormelink, R., Goldbach, R., De Haan, P., De Rover, A., Van Schepen, A., Gielen, J., Van Grinsven, M., Livneh, O., Vardi, E., Kuznetsova, L., Aliskevicius, E., Stram, Y., Sela, I., Dinant, S., Kusiak, C., Blaise, F., Chupeau, Y., Astier, S., Albouy, J., Clifford, T., Taylor, S., Stratford, R., Xiao, X., Frenkel, M., Chu, P., Tabe, L., Shukla, D., Ward, C., Hwang, Duk-Ju, Turner, Nilgun, Mooney, A., MacFarlane, S., Twell, D., Jacquet, C., Ravelonandro, M., Bachelier, J., Almási, A., Böddi, B., Szigeti, Z., Ekes, M., Gaborianvi, R., Yankulova, Margarita, Ivanova, Lidia, Adam, G., Guelemerov, S., Nikolaeva, Velitchka, Atanassov, A., Prins, Marcel, de Haan, Peter, Goldbach, Rob, Duan, Y., Powell, C., Purcifull, D., Hiebert, E., Levine, B., Faktor, O., Zeituny, Silvy, Edelbaum, Orit, Sela, L., Marano, Maria-Rosa, Ratcliff, Frank, Baulcombe, David, van Oers, Monique, Linthorst, Huub, Bol, John, Schillberg, S., Zimmermann, S., Drossard, J., Schumann, D., Nahring, J., Fischer, R., Lapidot, Moshe, Arce-Johnson, Patricio, Rivera-Bustamante, Rafael, Beachy, Roger, Cassidy, Brandt, Flasinski, Stanislaw, Hajimorad, M., Wesley, Varsha, Angel-Diaz, J., Mayo, M., Hafner, G., May, G., Becker, D., Arntzen, C., Porter, J., Hellwald, K., Banerjee, N., Zaitlin, M., Wolf, D., Faure, J., Pilowsky, M., Cohen, S., Zelcer, A., Hardi, V., Tomassoli, L., Kaniewski, W., Mitsky, T., Barba, M., Hou, Y., Ursin, V., Sanders, R., Gilbertson, R., Gruden, Kristina, Štrukelj, Borut, Brzin, Joze, Ravnikar, Maja, Maganja, Darja, Kregar, Igor, Maki-Valkama, T., Pehu, T., Valkonen, J., Lento, K., Pehu, E., Lawson, E., Feldman, J., Zalewski, J., Kuittinen, T., Atiri, G., Romero, A., Arroyo, R., Soto, M., Martínez-Zapater, J., Ponz, F., Gilardi, P., López, L., García-Luque, I., Serra, M., Pang, Sheng-Zhi, Jan, Fuh-Jyh, Carney, Kim, Tricoli, David, Quemada, Hector, Gonsalves, Dennis, Aboul-Ata, A., Thouvenel, J., Marshall, D., Abo-El-Saad, Sh, Satour, M., Mazithulela, G., Mehlo, L., Gahakwa, D., Leech, M., Boulton, M., Davies, J., Christou, P., Huet, H., Sivamani, E., Ong, C., Chen, L., de Kochko, A., Beachy, R., Fauquet, C., Sithisarn-Burns, P., Maugeri, M., Smith, G., Handley, J., Graichen, K., Peterka, J., Chu, Paul, Larkin, Phil, Higgins, T., Wylie, S., Jones, M., Somsap, V., Loo, H., Li, D., Mathews, A., Dwyer, G., McCarthy, P., Hansen, J., Shiel, P., Zemetra, R., Wyatt, S., Berger, P., Ford, C., Collins, N., Rathjen, J., Shams-Bakhsh, M., Paltridge, N., Makkouk, K., El-Saied, M., El-Hariry, M., Salem, G., Soliman, N., Rishi, Narayan, Lodhi, G., Bishnoi, S., Sangwan, R., Sijen, Titia, Wellink, Joan, van Kammen, Ab, Scorza, R., Callahan, A., Levy, L., Polák, J., Oukropec, I., Kominek, P., Bitoova, M., Cardol, Erwin, Kormelink, Richard, Baulcombe, D., English, J., Davenport, G., Ruiz-Perez, T., Mueller, E., Nigul, L., Kelve, M., Fedorkin, O., Denisenko, O., Zelenina, D., Morozov, S., Atabekov, J., Laliberté, J., Wittmann, S., Plante, Daniel, Fortin, Marc, Chatel, H., Rodriguez-Alvarado, G., Garcia-Arenal, F., Roossinck, M., Gellatly, D., Rasochova, L., Aulik, M., Passmore, B., Falk, B., Miller, W., Lin, Na-Sheng, Lin, Biing-Yuan, Hsu, Yau-Heiu, Tamada, T., Kiguchi, T., Saito, M., Kusume, T., Uchino, H., Taliansky, M., DiSerio, F., Daròs, J., Ragozzino, A., Floras, R., Hohn, Thomas, Chen, Gang, Rothnie, Helen, Corsten, Sandra, Fütterer, Johannes, Mikhailov, M., Bishop, D., Roy, P., Ramirez, E., Hernádez, A., Ham, E., Barrón, B., Ding, S., Li, W., Shi, B., Symons, R., Li, Q., Ryu, K., Palukaitis, P., Kaplan, I., Gal-On, A., Kunhara, J., Otsubo, T., Tomaru, K., Tsuda, S., Kinta, M., Lin, T., Johnson, J., Porta, C., Taylor, K., Spall, V., Lomonossoff, G., Meiri, E., Raccah, B., Gaba, V., Ikegami, M., Kawashima, H., Murayama, A., Natsuaki, T., Kageyama, Y., Sugimura, N., Thole, V., Bol, J., Deiman, B., Koenen, A., Pleij, C., Chaleeprom, W., Bateson, M., Dale, J., Badge, J., Foster, G., Brunt, A., Robinson, D., Schubert, J., Rabenstein, F., Merits, A., Yeh, Shyi-Dong, Chiang, Chu-Hui, Wang, Ching-Hsien, Golshani, A., Ivanov, I., AbouHaidar, M., Rodoni, B., Harding, R., Oertel, U., Fuchs, E., Yang, S., Revere, F., Walter, J., Le Gall, O., Dunez, J., Candresse, T., Lot, H., Souche, S., Kasschau, Kristin, Carrington, James, Chiang, A., Turner, N., Hwang, D., Chachulska, A., Zagórski, W., Robaglia, C., Chrzanowska, M., Truve, E., Tamm, T., Saarma, M., Makinen, K., Wang, Aiming, Carrier, Karma, Wieczorek, Andrew, Huguenot, Claire, Sanfacon, Helene, Wurscher, M., Christensen, F., Prody, G., Sanchez-Navarro, J., Pallas, V., Carson, R., Dagless, E., Lock, S., Turner, R., Adams, M., Antoniw, J., Phillips, S., Kashiwazaki, S., Seal, S., Karamagioli, M., Druka, Amis, Makhdoom, Rahat, Yitang, Yan, Hull, Roger, Kikkert, M., Bodegom, P., Storms, M., van Lent, J., Kormelink, R., Goldbach, R., De Haan, P., De Rover, A., Van Schepen, A., Gielen, J., Van Grinsven, M., Livneh, O., Vardi, E., Kuznetsova, L., Aliskevicius, E., Stram, Y., Sela, I., Dinant, S., Kusiak, C., Blaise, F., Chupeau, Y., Astier, S., Albouy, J., Clifford, T., Taylor, S., Stratford, R., Xiao, X., Frenkel, M., Chu, P., Tabe, L., Shukla, D., Ward, C., Hwang, Duk-Ju, Turner, Nilgun, Mooney, A., MacFarlane, S., Twell, D., Jacquet, C., Ravelonandro, M., Bachelier, J., Almási, A., Böddi, B., Szigeti, Z., Ekes, M., Gaborianvi, R., Yankulova, Margarita, Ivanova, Lidia, Adam, G., Guelemerov, S., Nikolaeva, Velitchka, Atanassov, A., Prins, Marcel, de Haan, Peter, Goldbach, Rob, Duan, Y., Powell, C., Purcifull, D., Hiebert, E., Levine, B., Faktor, O., Zeituny, Silvy, Edelbaum, Orit, Sela, L., Marano, Maria-Rosa, Ratcliff, Frank, Baulcombe, David, van Oers, Monique, Linthorst, Huub, Bol, John, Schillberg, S., Zimmermann, S., Drossard, J., Schumann, D., Nahring, J., Fischer, R., Lapidot, Moshe, Arce-Johnson, Patricio, Rivera-Bustamante, Rafael, Beachy, Roger, Cassidy, Brandt, Flasinski, Stanislaw, Hajimorad, M., Wesley, Varsha, Angel-Diaz, J., Mayo, M., Hafner, G., May, G., Becker, D., Arntzen, C., Porter, J., Hellwald, K., Banerjee, N., Zaitlin, M., Wolf, D., Faure, J., Pilowsky, M., Cohen, S., Zelcer, A., Hardi, V., Tomassoli, L., Kaniewski, W., Mitsky, T., Barba, M., Hou, Y., Ursin, V., Sanders, R., Gilbertson, R., Gruden, Kristina, Štrukelj, Borut, Brzin, Joze, Ravnikar, Maja, Maganja, Darja, Kregar, Igor, Maki-Valkama, T., Pehu, T., Valkonen, J., Lento, K., Pehu, E., Lawson, E., Feldman, J., Zalewski, J., Kuittinen, T., Atiri, G., Romero, A., Arroyo, R., Soto, M., Martínez-Zapater, J., Ponz, F., Gilardi, P., López, L., García-Luque, I., Serra, M., Pang, Sheng-Zhi, Jan, Fuh-Jyh, Carney, Kim, Tricoli, David, Quemada, Hector, Gonsalves, Dennis, Aboul-Ata, A., Thouvenel, J., Marshall, D., Abo-El-Saad, Sh, Satour, M., Mazithulela, G., Mehlo, L., Gahakwa, D., Leech, M., Boulton, M., Davies, J., Christou, P., Huet, H., Sivamani, E., Ong, C., Chen, L., de Kochko, A., Beachy, R., Fauquet, C., Sithisarn-Burns, P., Maugeri, M., Smith, G., Handley, J., Graichen, K., Peterka, J., Chu, Paul, Larkin, Phil, Higgins, T., Wylie, S., Jones, M., Somsap, V., Loo, H., Li, D., Mathews, A., Dwyer, G., McCarthy, P., Hansen, J., Shiel, P., Zemetra, R., Wyatt, S., Berger, P., Ford, C., Collins, N., Rathjen, J., Shams-Bakhsh, M., Paltridge, N., Makkouk, K., El-Saied, M., El-Hariry, M., Salem, G., Soliman, N., Rishi, Narayan, Lodhi, G., Bishnoi, S., Sangwan, R., Sijen, Titia, Wellink, Joan, van Kammen, Ab, Scorza, R., Callahan, A., Levy, L., Polák, J., Oukropec, I., Kominek, P., Bitoova, M., Cardol, Erwin, Kormelink, Richard, Baulcombe, D., English, J., Davenport, G., Ruiz-Perez, T., Mueller, E., Nigul, L., Kelve, M., Fedorkin, O., Denisenko, O., Zelenina, D., Morozov, S., Atabekov, J., Laliberté, J., Wittmann, S., Plante, Daniel, Fortin, Marc, Chatel, H., Rodriguez-Alvarado, G., Garcia-Arenal, F., Roossinck, M., Gellatly, D., Rasochova, L., Aulik, M., Passmore, B., Falk, B., Miller, W., Lin, Na-Sheng, Lin, Biing-Yuan, Hsu, Yau-Heiu, Tamada, T., Kiguchi, T., Saito, M., Kusume, T., Uchino, H., Taliansky, M., DiSerio, F., Daròs, J., Ragozzino, A., Floras, R., Hohn, Thomas, Chen, Gang, Rothnie, Helen, Corsten, Sandra, Fütterer, Johannes, Mikhailov, M., Bishop, D., and Roy, P.
- Published
- 2018
17. Immunization with the Malaria Diversity-Covering Blood-Stage Vaccine Candiate Plasmodium falciparum Apical Membrane Antigen 1 DiCo in Complex with Its Natural Ligand PfRpm2 Does Not Improve the In Vitro Efficacy
- Author
-
Spiegel, H., Boes, A., Fendel, R., Reimann, A., Schillberg, S., Fischer, R., and Publica
- Abstract
The blood-stage malaria vaccine candidate Plasmodium falciparum apical membrane antigen 1 (PfAMA1) can induce strong parasite growth-inhibitory antibody responses in animals but has not achieved the anticipated efficacy in clinical trials. Possible explanations in humans are the insufficient potency of the elicited antibody responses, as well as the high degree of sequence polymorphisms found in the field. Several strategies have been developed to improve the cross-strain coverage of PfAMA1-based vaccines, whereas innovative concepts to increase the potency of PfAMA1-specific IgG responses have received little attention even though this may be an essential requirement for protective efficacy. A previous study has demonstrated that immunization with a complex of PyAMA1 and PyRON2, a ligand with an essential functional role in erythrocyte invasion, leads to protection from lethal Plasmodium yoelli challenge in an animal model and suggested to extend this strategy toward improved strain coverage by using multiple PfAMA1 alleles in combination with PfRon2L. As an alternative approach along this line, we decided to use PfRon2L in combination with three PfAMA1 diversity covering variants (DiCo) to investigate the potential of this complex to induce more potent parasite growth inhibitory immune response in combination with better cross-strain-specific efficacy. Within the limits of the study design, the ability of the PfAMA1 DiCo-Mix to induce cross-strain-specific antibodies was not affected in all immunization groups, but the DiCo-PfRon2L complexes did not improve the potency of PfAMA1-specific IgG responses.
- Published
- 2017
18. Statistical experimental designs for the production of secondary metabolites in plant cell suspension cultures
- Author
-
Schmitz, C., Fritsch, L., Fischer, R., Schillberg, S., Rasche, S., and Publica
- Abstract
Statistical experimental designs, also known as the ""design of experiments"" (DoE) approach, are widely used to improve not only technical processes but also to answer questions in the agricultural, medical and social sciences. Although many articles have been published about the application of DoE in these fields, few studies have addressed the use of DoE in the plant sciences, particularly in the context of plant cell suspension cultures (PCSCs). Compounds derived from PCSCs can be developed as pharmaceuticals, chemical feedstocks and cosmetic ingredients, and statistical experimental designs can be used to improve the productivity of the cells and the yield and/or quality of the target compounds in a cost efficient manner. In this article, we summarize recent findings concerning the application of statistical approaches to improve the performance of PCSCs and discuss the potential future applications of this approach.
- Published
- 2016
19. Next-generation sequencing of amplicons is a rapid and reliable method for the detection of polymorphisms relevant for barley breeding
- Author
-
Fritsch, L., Soeur, R., Hansen, C., Fischer, R., Schillberg, S., Schröper, F., and Publica
- Abstract
Modern plant breeding is based on the detection of traits at the molecular level so that the selection process can be accelerated. Methods that allow the rapid and high-throughput analysis of such traits are therefore useful for plant breeders and farmers. We have shown that next-generation sequencing, applied to short PCR products spanning or flanking polymorphisms of interest in barley, can provide robust genotyping data that allow the rapid determination of genotype and zygosity. This method can be used to genotype large panels of plants because up to 80 million individual reads can be produced in one sequencing run, and samples from different lines and/or traits can be pooled. These findings are significant because plant breeders may need to screen large populations for multiple traits in parallel.
- Published
- 2016
20. Thanatin confers partial resistance against aflatoxigenic fungi in maize (Zea mays)
- Author
-
Schubert, M., Houdelet, M., Kogel, K.-H., Fischer, R., Schillberg, S., Nölke, G., and Publica
- Abstract
Aflatoxin-producing fungi can contaminate plants and plant-derived products with carcinogenic secondary metabolites that present a risk to human and animal health. In this study, we investigated the effect of antimicrobial peptides on the major aflatoxigenic fungi Aspergillus flavus and A. parasiticus. In vitro assays with different chemically-synthesized peptides demonstrated that the broad-spectrum peptide thanatin from the spined soldier bug (Podisus maculiventris) had the greatest potential to eliminate aflatoxigenic fungi. The minimal inhibitory concentrations of thanatin against A. flavus and A. parasiticus were 3.13 and 12.5 µM, respectively. A thanatin cDNA was subsequently cloned in a plant expression vector under the control of the ubiquitin-1 promoter allowing the recombinant peptide to be directed to the apoplast in transgenic maize plants. Successful integration of the thanatin expression cassette was confirmed by PCR and expression was demonstrated by semi-quantitative RT-PCR in transgenic maize kernels. Infection assays with maize kernels from T1 transgenic plants showed up to three-fold greater resistance against Aspergillus spp. infections compared to non-transgenic kernels. We demonstrated for the first time that heterologous expression of the antimicrobial peptide thanatin inhibits the growth of Aspergillus spp. in transgenic maize plants offering a solution to protect crops from aflatoxin-producing fungi and the resulting aflatoxin contamination in the field and under storage conditions.
- Published
- 2015
21. High-value products from plants: the challenges of process optimization
- Author
-
Fischer, R., Vasilev, N., Twyman, R.M., Schillberg, S., and Publica
- Abstract
Plants can be used to produce a diverse repertoire of complex small-molecule compounds and recombinant proteins that are valuable as industrial and pharmaceutical products. But as we move from proof-of-principle experiments and begin to consider the realistic prospects of commercial production, the focus must shift from the achievement of target molecule production and move towards quality, purity and yield aspects that determine commercial feasibility. This review describes some of the recent advances that have been implemented to improve the development of integrated production processes for high-value molecules expressed in plants, including the introduction of novel procedures to increase the likelihood of regulatory acceptance.
- Published
- 2015
22. A versatile coupled cell-free transcription-translation system based on tobacco BY-2 cell lysates
- Author
-
Buntru, M., Vogel, S., Stoff, K., Spiegel, H., Schillberg, S., and Publica
- Abstract
Cell-free protein synthesis is a powerful method for the high-throughput production of recombinant proteins, especially proteins that are difficult to express in living cells. Here we describe a coupled cell-free transcription-translation system based on tobacco BY-2 cell lysates (BYLs). Using a combination of fractional factorial designs and response surface models, we developed a cap-independent system that produces more than 250 mg/mL of functional enhanced yellow fluorescent protein (eYFP) and about 270 mg/mL of firefly luciferase using plasmid templates, and up to 180 mg/mL eYFP using linear templates (PCR products) in 18 h batch reactions. The BYL contains actively-translocating microsomal vesicles derived from the endoplasmic reticulum, promoting the formation of disulfide bonds, glycosylation and the cotranslational integration of membrane proteins. This was demonstrated by expressing a functional full-size antibody (∼150 mg/mL), the model enzyme glucose oxidase (GOx) (∼7.3 U/mL), and a transmembrane growth factor (∼25 mg/mL). Subsequent in vitro treatment of GOx with peptide-N-glycosidase F confirmed the presence of N-glycans. Our results show that the BYL can be used as a high-throughput expression and screening platform that is particularly suitable for complex and cytotoxic proteins.
- Published
- 2015
23. Optimization of a multi-stage, multi-subunit malaria vaccine candidate for the production in Pichia pastoris by the identification and removal of protease cleavage sites
- Author
-
Spiegel, H., Schinkel, H., Kastilan, R., Dahm, P., Boes, A., Scheuermayer, M., Chudobova, I., Maskus, D., Fendel, R., Schillberg, S., Reimann, A., Fischer, R., and Publica
- Abstract
We demonstrated the successful optimization of a recombinant multi-subunit malaria vaccine candidate protein for production in the methylotrophic yeast Pichia pastoris by the identification and subsequent removal of two protease cleavage sites. After observing protein degradation in the culture supernatant of a fed-batch fermentation, the predominant proteolytic fragment of the secreted recombinant protein was analyzed by mass spectrometry. The MS data indicated the cleavage of an amino acid sequence matching the yeast KEX2-protease consensus motif EKRE. The cleavage in this region was completely abolished by the deletion of the EKRE motif in a modified variant. This modified variant was produced, purified, and used for immunization of rabbits, inducing high antigen specific antibody titers (2x10(6)). Total IgG from rabbit immune sera recognized different stages of Plasmodium falciparum parasites in immunofluorescence assays, indicating native folding of the vaccine candidate. However, the modified variant was still degraded, albeit into different fragments. Further analysis by mass spectrometry and N-terminal sequencing revealed a second cleavage site downstream of the motif PEVK. We therefore removed a 17-amino-acid stretch including the PEVK motif, resulting in the subsequent production of the full-length recombinant vaccine candidate protein without significant degradation, with a yield of 53mg per liter culture volume. We clearly demonstrate that the proteolytic degradation of recombinant proteins by endogenous P. pastoris proteases can be prevented by the identification and removal of such cleavage sites. This strategy is particularly relevant for the production of recombinant subunit vaccines, where product yield and stability play a more important role than for the production of a stringently-defined native sequence which is necessary for most therapeutic molecules.
- Published
- 2015
24. Next-generation sequencing is a robust strategy for the high-throughput detection of zygosity in transgenic maize
- Author
-
Fritsch, L., Fischer, R., Wambach, C., Dudek, M., Schillberg, S., Schroper, F., and Publica
- Abstract
Simple and reliable, high-throughput techniques to detect the zygosity of transgenic events in plants are valuable for biotechnology and plant breeding companies seeking robust genotyping data for the assessment of new lines and the monitoring of breeding programs. We show that next-generation sequencing (NGS) applied to short PCR products spanning the transgene integration site provides accurate zygosity data that are more robust and reliable than those generated by PCR-based methods. The NGS reads covered the 5' border of the transgenic events (incorporating part of the transgene and the flanking genomic DNA), or the genomic sequences flanking the unfilled transgene integration site at the wild-type locus. We compared the NGS method to competitive real-time PCR with transgene-specific and wild-type-specific primer/probe pairs, one pair matching the 5' genomic flanking sequence and 5' part of the transgene and the other matching the unfilled transgene integration site. Although both NGS and real-time PCR provided useful zygosity data, the NGS technique was favorable because it needed fewer optimization steps. It also provided statistically more-reliable evidence for the presence of each allele because each product was often covered by more than 100 reads. The NGS method is also more suitable for the genotyping of large panels of plants because up to 80 million reads can be produced in one sequencing run. Our novel method is therefore ideal for the rapid and accurate genotyping of large numbers of samples.
- Published
- 2015
25. The stage-specific in vitro efficacy of a malaria antigen cocktail provides valuable insights into the development of effective multi-stage vaccines
- Author
-
Spiegel, H., Boes, A., Kastilan, R., Kapelski, S., Edgue, G., Beiss, V., Chubodova, I., Scheuermayer, M., Pradel, G., Schillberg, S., Reimann, A., Fischer, R., and Publica
- Abstract
Multicomponent vaccines targeting different stages of Plasmodium falciparum represent a promising, holistic concept towards better malaria vaccines. Additionally, an effective vaccine candidate should demonstrate cross-strain specificity because many antigens are polymorphic, which can reduce vaccine efficacy. A cocktail of recombinant fusion proteins (VAMAX-Mix) featuring three diversity-covering variants of the blood-stage antigen PfAMA1, each combined with the conserved sexual-stage antigen Pfs25 and one of the pre-erythrocytic-stage antigens PfCSP_TSR or PfCelTOS, or the additional blood-stage antigen PfMSP1_19, was produced in Pichia pastoris and used to immunize rabbits. The immune sera and purified IgG were used to perform various assays determining antigen specific titers and in vitro efficacy against different parasite stages and strains. In functional in vitro assays we observed robust inhibition of blood-stage (up to 90%), and sexual-stage parasites (up to 10 0%) and biased inhibition of pre-erythrocytic parasites (0-40%). Cross-strain blood-stage efficacy was observed in erythrocyte invasion assays using four different P. falciparum strains. The quantification of antigen-specific IgGs allowed the determination of specific IC50 values. The significant difference in antigen-specific IC50 requirements, the direct correlation between antigen-specific IgG and the relative quantitative representation of antigens within the cocktail, provide valuable implementations for future multi-stage, multi-component vaccine designs.
- Published
- 2015
26. Scaled-up manufacturing of recombinant antibodies produced by plant cells in a 200-L orbitally-shaken disposable bioreactor
- Author
-
Raven, N., Rasche, F., Kuehn, C., Anderlei, T., Klöckner, W., Schuster, F., Henquet, M.G.L., Bosch, H.J., Büchs, J., Fischer, R., Schillberg, S., and Publica
- Subjects
cho-cells ,purification ,technology, industry, and agriculture ,high-yield production ,equipment and supplies ,suspension-cultures ,foreign proteins ,pharmaceutical proteins ,expanded-bed adsorption ,BIOS Applied Metabolic Systems ,full-size antibody ,monoclonal-antibody ,Laboratorium voor Plantenfysiologie ,Laboratory of Plant Physiology ,enzyme replacement therapy - Abstract
Tobacco BY-2 cells have emerged as a promising platform for the manufacture of biopharmaceutical proteins, offering efficient protein secretion, favourable growth characteristics and cultivation in containment under a controlled environment. The cultivation of BY-2 cells in disposable bioreactors is a useful alternative to conventional stainless steel stirred-tank reactors, and orbitally-shaken bioreactors could provide further advantages such as simple bag geometry, scalability and predictable process settings. We carried out a scale-up study, using a 200-L orbitally-shaken bioreactor holding disposable bags, and BY-2 cells producing the human monoclonal antibody M12. We found that cell growth and recombinant protein accumulation were comparable to standard shake flask cultivation, despite a 200-fold difference in cultivation volume. Final cell fresh weights of 300-387 g/L and M12 yields of ∼20 mg/L were achieved with both cultivation methods. Furthermore, we established an efficient downstream process for the recovery of M12 from the culture broth. The viscous spent medium prevented clarification using filtration devices, but we used expanded bed adsorption (EBA) chromatography with SP Sepharose as an alternative for the efficient capture of the M12 antibody. EBA was introduced as an initial purification step prior to protein A affinity chromatography, resulting in an overall M12 recovery of 75-85% and a purity of >95%. Our results demonstrate the suitability of orbitally-shaken bioreactors for the scaled-up cultivation of plant cell suspension cultures and provide a strategy for the efficient purification of antibodies from the BY-2 culture medium.
- Published
- 2015
27. Detailed functional characterization of glycosylated and nonglycosylated variants of malaria vaccine candidate PfAMA1 produced in Nicotiana benthamiana and analysis of growth inhibitory responses in rabbits
- Author
-
Boes, A., Spiegel, H., Edgue, G., Kapelski, S., Scheuermayer, M., Fendel, R., Remarque, E., Altmann, F., Maresch, D., Reimann, A., Pradel, G., Schillberg, S., Fischer, R., and Publica
- Abstract
One of the most promising malaria vaccine candidate antigens is the Plasmodium falciparum apical membrane antigen 1 (PfAMA1). Several studies have shown that this blood-stage antigen can induce strong parasite growth inhibitory antibody responses. PfAMA1 contains up to six recognition sites for N-linked glycosylation, a post-translational modification that is absent in P. falciparum. To prevent any potential negative impact of N-glycosylation, the recognition sites have been knocked out in most PfAMA1 variants expressed in eukaryotic hosts. However, N-linked glycosylation may increase efficacy by improving immunogenicity and/or focusing the response towards relevant epitopes by glycan masking. We describe the production of glycosylated and nonglycosylated PfAMA1 in Nicotiana benthamiana and its detailed characterization in terms of yield, integrity and protective efficacy. Both PfAMA1 variants accumulated to high levels (>510 mg/g fresh leaf weight) after transient ex pression, and high-mannose-type N-glycans were confirmed for the glycosylated variant. No significant differences between the N. benthamiana and Pichia pastoris PfAMA1 variants were detected in conformation-sensitive ligand-binding studies. Specific titres of >2 × 106 were induced in rabbits, and strong reactivity with P. falciparum schizonts was observed in immunofluorescence assays, as well as up to 100% parasite growth inhibition for both variants, with IC50 values of ~35 mg/mL. Competition assays indicated that a number of epitopes were shielded from immune recognition by N-glycans, warranting further studies to determine how glycosylation can be used for the directed targeting of immune responses. These results highlight the potential of plant transient expression systems as a production platform for vaccine candidates.
- Published
- 2015
28. Heat-precipitation allows the efficient purification of a functional plant-derived malaria transmission-blocking vaccine candidate fusion protein
- Author
-
Beiss, V., Spiegel, H., Boes, A., Kapelski, S., Scheuermayer, M., Edgue, G., Sack, M., Fendel, R., Reimann, A., Schillberg, S., Pradel, G., Fischer, R., and Publica
- Abstract
Malaria is a vector-borne disease affecting more than two million people and accounting for more than 600,000 deaths each year, especially in developing countries. The most serious form of malaria is caused by Plasmodium falciparum. The complex life cycle of this parasite, involving pre-erythrocytic, asexual and sexual stages, makes vaccine development cumbersome but also offers a broad spectrum of vaccine candidates targeting exactly those stages. Vaccines targeting the sexual stage of P. falciparum are called transmission-blocking vaccines (TBVs). They do not confer protection for the vaccinated individual but aim to reduce or prevent the transmission of the parasite within a population and are therefore regarded as an essential tool in the fight against the disease. Malaria predominantly affects large populations in developing countries, so TBVs need to be produced in large quantities at low cost. Combining the advantages of eukaryotic expression with a virtually unlimited upscaling potential and a good product safety profile, plant-based expression systems represent a suitable alternative for the production of TBVs. We report here the high level (300g/g fresh leaf weight (FLW)) transient expression in Nicotiana benthamiana leaves of an effective TBV candidate based on a fusion protein F0 comprising Pfs25 and the C0-domain of Pfs230, and the implementation of a simple and cost-effective heat treatment step for purification that yields intact recombinant protein at >90% purity with a recovery rate of >70%. The immunization of mice clearly showed that antibodies raised against plant-derived F0 completely blocked the formation of oocysts in a malaria transmission-blocking assay (TBA) making F0 an interesting TBV candidate or a component of a multi-stage malaria vaccine cocktail.
- Published
- 2015
29. Characterization of a plant-derived malaria vaccine candidate based on a Plasmodium falciparum sexual-stage fusion protein
- Author
-
Beiss, V, Boes, A, Spiegel, H, Kapelski, S, Scheuermayer, M, Edgue, G, Sack, M, Reimann, A, Schillberg, S, Pradel, G, and Fischer, R
- Subjects
ddc: 610 ,610 Medical sciences ,Medicine - Abstract
Plants provide a low-cost production platform for vaccines targeting poverty-related diseases such as malaria, although the feasibility of production depends on the functional efficacy, stability, yield and purification of the vaccine. Here we describe the high-level production and functional characterization[for full text, please go to the a.m. URL], 12th Malaria Meeting
- Published
- 2014
- Full Text
- View/download PDF
30. Contained molecular farming:Controllable contained systems for high yield and consistency (CoMoFarm)
- Author
-
Ritala, Anneli, Häkkinen, Suvi, Oksman-Caldentey, Kirsi-Marja, Raven, N., Schillberg, S., Henquet, M., and Bosch, D.
- Published
- 2014
31. Malaria vaccine candidate antigen targeting the pre-erythrocytic stage of Plasmodium falciparum produced at high level in plants
- Author
-
Voepel, N., Boes, A., Edgue, G., Beiss, V., Kapelski, S., Reimann, A., Schillberg, S., Pradel, G., Fendel, R., Scheuermayer, M., Spiegel, H., Fischer, R., and Publica
- Abstract
Plants have emerged as low-cost production platforms suitable for vaccines targeting poverty-related diseases. Besides functional efficacy, the stability, yield, and purification process determine the production costs of a vaccine and thereby the feasibility of plant-based production. We describe high-level plant production and functional characterization of a malaria vaccine candidate targeting the pre-erythrocytic stage of Plasmodium falciparum. CCT, a fusion protein composed of three sporozoite antigens (P. falciparum cell traversal protein for ookinetes and sporozoites [PfCelTOS], P. falciparum circumsporozoite protein [PfCSP], and P. falciparum thrombospondin-related adhesive protein [PfTRAP]), was transiently expressed by agroinfiltration in Nicotiana benthamiana leaves, accumulated to levels up to 2 mg/g fresh leaf weight (FLW), was thermostable up to 80 degrees C and could be purified to >95% using a simple two-step procedure. Reactivity of sera from malaria semi-immune donors indicated the immunogenic conformation of the purified fusion protein consisting of PfCelTOS, PfCSP_TSR, PfTRAP_TSR domains (CCT) protein. Total IgG from the CCT-specific mouse immune sera specifically recognized P. falciparum sporozoites in immunofluorescence assays and induced up to 35% inhibition in hepatocyte invasion assays. Featuring domains from three promising sporozoite antigens with different roles (attachment and cell traversal) in the hepatocyte invasion process, CCT has the potential to elicit broader immune responses against the pre-erythrocytic stage of P. falciparum and represents an interesting new candidate, also as a component of multi-stage, multi-subunit malaria vaccine cocktails.
- Published
- 2014
32. Molecular farming in tobacco hairy roots by triggering the secretion of a pharmaceutical antibody
- Author
-
Häkkinen, S.T., Raven, N., Henquet, M.G.L., Laukkanen, M.L., Anderlei, T., Pitkänen, J.P., Twyman, R.M., Bosch, H.J., Oksman-Caldentey, K.M., Schillberg, S., Ritala, A., and Publica
- Subjects
glucocerebrosidase ,transgenic plants ,recombinant proteins ,nitrogen ,tissue-cultures ,hyoscyamus-muticus ,BIOS Applied Metabolic Systems ,monoclonal-antibody ,Laboratorium voor Plantenfysiologie ,cell-suspension-culture ,optimization ,Laboratory of Plant Physiology ,enzyme replacement therapy - Abstract
Recombinant pharmaceutical proteins expressed in hairy root cultures can be secreted into the medium to improve product homogeneity and to facilitate purification, although this may result in significant degradation if the protein is inherently unstable or particularly susceptible to proteases. To address these challenges, we used a design of experiments approach to develop an optimized induction protocol for the cultivation of tobacco hairy roots secreting the full-size monoclonal antibody M12. The antibody yield was enhanced 30-fold by the addition of 14¿g/L KNO3, 19¿mg/L 1-naphthaleneacetic acid and 1.5¿g/L of the stabilizing agent polyvinylpyrrolidone. Analysis of hairy root cross sections revealed that the optimized medium induced lateral root formation and morphological changes in the inner cortex and pericycle cells, indicating that the improved productivity was at least partially based on the enhanced efficiency of antibody secretion. We found that 57% of the antibody was secreted, yielding 5.9¿mg of product per liter of induction medium. Both the secreted and intracellular forms of the antibody could be isolated by protein A affinity chromatography and their functionality was confirmed using vitronectin-binding assays. Glycan analysis revealed three major plant complex-type glycans on both forms of the antibody, although the secreted form was more homogeneous due to the predominance of a specific glycoform. Tobacco hairy root cultures therefore offer a practical solution for the production of homogeneous pharmaceutical antibodies in containment. Biotechnol. Bioeng. 2013;9999: 1–11.
- Published
- 2014
33. The expression of a recombinant glycolate dehydrogenase polyprotein in potato (Solanum tuberosum) plastids strongly enhances photosynthesis and tuber yield
- Author
-
Nölke, G., Houdelet, M., Kreuzaler, F., Peterhänsel, C., Schillberg, S., and Publica
- Subjects
nitrate assimilation ,photorespiration ,biomass ,carbon metabolism ,starch ,carbon ,fungi ,food and beverages ,arabidopsis-thaliana ,transgenic plants ,tuber size ,ddc:580 ,plant-growth ,Dewey Decimal Classification::500 | Naturwissenschaften::580 | Pflanzen (Botanik) ,gas-chromatography ,chloroplasts ,escherichia-coli ,metabolism - Abstract
We have increased the productivity and yield of potato (Solanum tuberosum) by developing a novel method to enhance photosynthetic carbon fixation based on expression of a polyprotein (DEFp) comprising all three subunits (D, E and F) of Escherichia coli glycolate dehydrogenase (GlcDH). The engineered polyprotein retained the functionality of the native GlcDH complex when expressed in E. coli and was able to complement mutants deficient for the D, E and F subunits. Transgenic plants accumulated DEFp in the plastids, and the recombinant protein was active in planta, reducing photorespiration and improving CO2 uptake with a significant impact on carbon metabolism. Transgenic lines with the highest DEFp levels and GlcDH activity produced significantly higher levels of glucose (5.8-fold), fructose (3.8-fold), sucrose (1.6-fold) and transitory starch (threefold), resulting in a substantial increase in shoot and leaf biomass. The higher carbohydrate levels produced in potato leaves were utilized by the sink capacity of the tubers, increasing the tuber yield by 2.3-fold. This novel approach therefore has the potential to increase the biomass and yield of diverse crops.
- Published
- 2014
- Full Text
- View/download PDF
34. Image-based analysis of cell-specific productivity for plant cell suspension cultures
- Author
-
Havenith, H., Raven, N., Fiore, S. di, Fischer, R., Schillberg, S., and Publica
- Abstract
More and more plant cell suspension cultures are regarded as an attractive alternative to mammalian cells as host organism for production of complex recombinant proteins. The most important advantages of the production platform are low costs, easy scalability and enhanced safety by complete lack of animal components in the cultivation media. In order to characterize, understand and control such systems accurately, it is important to determine the cell-specific productivity (Qp) of plant cell-based production platforms. Compared to many microbial and mammalian cells the morphology of plant cells is nonhomogeneous and the cells tend to form aggregates, therefore commercial cell counting systems are too unreliable to determine cell numbers in plant suspension cultures. We addressed this limitation by developing a novel cell counting method based on a combination of cell-staining and automated confocal fluorescence microscopy. This method allowed us, for the first time, to determine the cell-specific productivity of transgenic tobacco (Nicotiana tabacum cv. Bright Yellow-2) cell suspension cultures producing the human antibody M12. In the future this method will be a useful tool in the development of optimized plant cell-based production processes.
- Published
- 2014
35. Analysis of a Multi-component Multi-stage Malaria Vaccine Candidate-Tackling the Cocktail Challenge.
- Author
-
Boes, A., Spiegel, H., Voepel, N., Edgue, G., Beiss, V., Kapelski, S., Fendel, R., Scheuermayer, M., Pradel, G., Bolscher, J.M., Behet, M.C., Dechering, K.J., Hermsen, C.C., Sauerwein, R.W., Schillberg, S., Reimann, A., Fischer, R., Boes, A., Spiegel, H., Voepel, N., Edgue, G., Beiss, V., Kapelski, S., Fendel, R., Scheuermayer, M., Pradel, G., Bolscher, J.M., Behet, M.C., Dechering, K.J., Hermsen, C.C., Sauerwein, R.W., Schillberg, S., Reimann, A., and Fischer, R.
- Abstract
Contains fulltext : 154144.PDF (publisher's version ) (Open Access)
- Published
- 2015
36. Transgenic Tobacco BY-2 cell efficiently express human tissue transglutaminase
- Author
-
SORRENTINO, ANGELA, PORTA, RAFFAELE, MARINIELLO, LOREDANA, SCHILLBERG S., FISHER R., Sorrentino, Angela, Schillberg, S., Fisher, R., Porta, Raffaele, and Mariniello, Loredana
- Published
- 2004
37. Production of a pharmaceutical antibody in tobacco hairy roots:FP7 CoMoFarm project
- Author
-
Häkkinen, Suvi T., Raven, N., Henquet, M., Laukkanen, Marja-Leena, Anderlei, T., Bosch, D., Oksman-Caldentey, Kirsi-Marja, Schillberg, S., and Ritala, Anneli
- Published
- 2013
38. Commercial aspects of pharmaceutical protein production in plants
- Author
-
Fischer, R., Schillberg, S., Buyel, J.F., Twyman, R.M., and Publica
- Abstract
Many different plant-based systems have been used to produce recombinant pharmaceutical proteins but only a small number have made the leap from an experimental platform to a viable commercial process. This reflects a combination of factors, principally the technical issues that must be addressed to achieve competitive performance, the economic principles that need to be satisfied to ensure manufacturing processes are financially viable and sustainable, and the regulatory demands that must be met to ensure that pharmaceuticals manufactured in plants are safe, efficacious and meet the quality standards demanded by the regulators. With the recent approval of the first plant-derived recombinant pharmaceutical protein designated for human use, we are now entering a new era in which plants not only meet all the demands of a commercial pharmaceutical manufacturing process but also provide unique benefits that allow the displacement of established platform technologies in niche markets. In this article, we consider the commercial aspects of molecular farming, specifically those required to make plants more competitive and attractive to industry.
- Published
- 2013
39. Corrigendum to 'Antibody-mediated resistance against plant pathogens' [Biotechnol Adv 29 (6) (2011) 961-971] (DOI:10.1016/j.biotechadv.2011.08.011)
- Author
-
Safarnejad, M.R., Jouzani, G.S., Tabatabaei, M., Twyman, R.M., Schillberg, S., and Publica
- Published
- 2012
40. GMP issues for recombinant plant-derived pharmaceutical proteins
- Author
-
Fischer, R., Schillberg, S., Hellwig, S., Twyman, R.M., Drossard, J., and Publica
- Abstract
Recombinant proteins can be produced in a diverse array of plant-based systems, ranging from whole plants growing in the soil to plant suspension cells growing in a fully-defined synthetic medium in a bioreactor. When the recombinant proteins are intended for medical use (plant-derived pharmaceutical proteins, PDPs) they fall under the same regulatory guidelines for manufacturing that cover drugs from all other sources, and when such proteins enter clinical development this includes the requirement for production according to good manufacturing practice (GMP). In principle, the well-characterized GMP regulations that apply to pharmaceutical proteins produced in bacteria and mammalian cells are directly transferrable to plants. In practice, the cell-specific terminology and the requirement for a contained, sterile environment mean that only plant cells in a bioreactor fully meet the original GMP criteria. Significant changes are required to adapt these regulations for pr oteins produced in whole-plant systems and it is only recently that the first GMP-compliant production processes using plants have been delivered.
- Published
- 2012
41. Prozessentwicklung und -übertragung vom 50-ml- auf den 10-l-Maßstab
- Author
-
Brändli, J., Müller, M., Imseng, N., Schillberg, S., Eibl, R., and Publica
- Abstract
Engineered plant cells can be used in order to produce antibodies. Suitable methods for process development and scale-up allow fast production of pre-clinical antibody samples in single-use bioreactors.
- Published
- 2012
42. Der mobile Pflanzendoktor
- Author
-
Jungk, F., Schillberg, S., Krause, H.-J., Schröper, F., and Publica
- Subjects
Grapevine Fanleaf Virus ,Immunofiltration ,Schnelltest ,Frequenzmischung - Abstract
Die frühzeitige Identifizierung pathogenen Befalls bei Kulturpflanzen ist für Landwirte von großer Bedeutung. Derzeit existieren keine Schnelltests, die in ihrer Sensitivität vergleichbar mit einer aufwändigen Laboruntersuchung sind. Das hier vorgestellte Detektionsprinzip ermöglicht es dem Landwirt die Untersuchung seiner Pflanzen vor Ort selbst durchzuführen. Mittels magnetischer Immunofiltration und mit Hilfe eines tragbaren Lesegerätes gelingt die zuverlässige Pathogendetektion innerhalb weniger Minuten.
- Published
- 2011
43. Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco
- Author
-
Boes, A., Spiegel, H., Delbrück, H., Fischer, R., Schillberg, S., Sack, M., and Publica
- Subjects
protein L ,Molecular Farming ,recombinant antibodies ,protein engineering ,immunoglobulin A ,biological ,surface plasmon resonance - Abstract
Complex multimeric proteins such as dimeric and secretory immunoglobulin A (IgA) can be difficult to produce in heterologous systems, although this has been achieved using several platforms including plants. As well as topical mucosal applications, dimeric IgA (dIgA), and secretory IgA (sIgA) can be used in tumor and anti-viral therapy, where their more potent cell-killing properties may increase their efficacy compared to current drugs based on IgG. However, the development of therapeutic IgA formats is hampered by the need to co-express four different polypeptides, and the inability to purify such molecules using conventional protein A or protein G affinity chromatography. The light chain (LC)-specific affinity ligand protein L is a potential alternative, but it only recognizes certain kappa light chain (LC(?)) subtypes. To overcome these limitations, we have adapted a framework-grafting approach to introduce LCs that bind protein L into any IgA. As a model, we used the chimeric anti-human chorionic gonadotropin (hCG) antibody cPIPP, since this contains a murine LC(?) subtype that does not bind protein L. Grafting was achieved by replacing selected framework region 1 (FR1) residues in the cPIPP LC(?) variable domain with corresponding residues from LC(?) subtypes that can bind protein L. The grafted antibody variants were successfully purified by protein L affinity chromatography. These modifications affected neither their antigen-binding properties nor the yields achieved by transient expression in tobacco plants. Our results therefore show that LC FR1 grafting can be used as generic strategy for the purification of IgA molecules.
- Published
- 2011
44. Biochemical properties of the matrix metalloproteinase NtMMP1 from Nicotiana tabacum cv. BY-2 suspension cells
- Author
-
Mandal, M.K., Fischer, R., Schillberg, S., Schiermeyer, A., and Publica
- Published
- 2010
45. Holistic approach to malaria elimination
- Author
-
Boes, A, Spiegel, H, Beiss, V, Edgü, G, Schinkel, H, Houdelet, M, Schillberg, S, Sack, M, Rademacher, T, Dahm, P, Kastilan, R, Buyel, J, Holland, T, Blessing, D, Vöpel, N, Hellwig, S, Drossard, J, Fendel, R, Kapelski, S, Maskus, D, Addai-Mensah, O, Seidel, M, Barth, S, Geese, M, Reiss, K, Wenzel, C, Hügel, C, Scholz, O, Kostka, G, Benz, M, Haßlmeyer, E, Münzenmayer, C, Weigand, C, Scheuermayer, M, Pradel, G, Remarque, E, Faber, B, Horstmann, R, Tannich, E, Fischer, R, Reimann, A, Boes, A, Spiegel, H, Beiss, V, Edgü, G, Schinkel, H, Houdelet, M, Schillberg, S, Sack, M, Rademacher, T, Dahm, P, Kastilan, R, Buyel, J, Holland, T, Blessing, D, Vöpel, N, Hellwig, S, Drossard, J, Fendel, R, Kapelski, S, Maskus, D, Addai-Mensah, O, Seidel, M, Barth, S, Geese, M, Reiss, K, Wenzel, C, Hügel, C, Scholz, O, Kostka, G, Benz, M, Haßlmeyer, E, Münzenmayer, C, Weigand, C, Scheuermayer, M, Pradel, G, Remarque, E, Faber, B, Horstmann, R, Tannich, E, Fischer, R, and Reimann, A
- Published
- 2014
46. Generation and characterization of a recombinant antibody fragment that binds to the coat protein of grapevine leafroll-associated virus 3
- Author
-
Orecchia, M., Nölke, G., Saldarelli, P., Dell´Orco, M., Uhde-Holzem, K., Sack, M., Martelli, G., Fischer, R., Schillberg, S., and Publica
- Published
- 2008
47. Generation and evaluation of movement protein-specific single-chain antibodies for delaying symptoms of Tomato spotted wilt virus infection in tobacco
- Author
-
Zhang, M.Y., Zimmermann, S., Fischer, R., Schillberg, S., and Publica
- Abstract
This study investigated whether single-chain antibodies (scFvs) specific for a viral movement protein could accumulate in the plant cell cytosol and restrict viral systemic infection in plants. Nine chicken scFv fragments against the Tomato spotted wilt virus (TSWV) movement protein (NSM) were isolated by phage display. Soluble scFvs were produced in bacteria and the NSM binding activity of purified scFvs was confirmed. The nine scFv genes were cloned into a plant expression vector enabling recombinant protein accumulation in the plant cell cytosol. Immunoblot analysis demonstrated that two of the nine chicken scFvs accumulated to high levels (5.9 and 8.0% of total soluble protein). Bioassays of viral infection using transgenic tobacco plants producing NSM-specific chicken scFvs showed delayed symptom development when compared to non-transgenic control plants, indicating that expression of antibodies recognizing the TSWV movement protein is a potential strategy for generating resistant plants.
- Published
- 2008
48. EXPRESSION OF THE ANTI-INFLAMMATORY CYTOKINE IL-10 IN TOBACCO
- Author
-
Bortesi, Luisa, Avesani, Linda, Raven, N, Bock, R, Schillberg, S, and Pezzotti, Mario
- Published
- 2007
49. Molecular farming for new drugs and vaccines
- Author
-
Ma, J.K.-C., Barros, E., Bock, R., Christou, P., Dale, P.J., Dix, P.J., Fischer, R., Irwin, J., Mahoney, R., Pezzotti, M., Schillberg, S., Sparrow, P., Stoger, E., Twyman, R.M., and Publica
- Published
- 2005
50. Production of recombinant human serum albumin in transgenic plant suspension cell cultures
- Author
-
Mavituna, M., Fischer, R., Schillberg, S., and Publica
- Published
- 2005
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.